Associate Director, New Product Planning & Competitive Intelligence
Zenas BioPharmaWaltham, Massachusetts, United States · Posted 10 days agoDescription
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcγRIIb monoclonal antibody.
We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation!
Position Summary:
Zenas BioPharma is seeking an experienced Associate Director, New Product Planning & Competitive Intelligence to proactively support and advance the company’s New Product Planning and Competitive Intelligence activities. Reporting to the Vice President of Corporate Development and New Product Planning, this individual will play a critical role in advancing Zenas BioPharma’s ambition to build a robust and differentiated I&I portfolio.
The Associate Director will help ensure that Zenas remains at the forefront of evolving market trends, competitor strategies, and emerging opportunities, while also supporting business development diligence and portfolio strategy efforts. This individual will bring deep expertise in disease-area opportunity assessment, competitive intelligence, and business and corporate strategy, helping to inform strategic decision-making and position the organization for long-term success.
Key Responsibilities:
- Support competitive intelligence (CI) activities for pipeline programs, monitoring competitor pipelines, clinical and regulatory developments, commercial activity, business development, and market trends.
- Developing CI planners (Excel) and coverage summaries (PowerPoint) for medical conferences
- Attending conferences and sharing timely, relevant CI updates with key stakeholders
- Producing post-conference summary reports
- Contribute to New Product Planning activities, including disease-area opportunity assessments, evaluation of emerging mechanisms and technologies, and development of strategic recommendations to inform pipeline and portfolio decisions
- Conduct primary and secondary research and support congress coverage, synthesizing emerging data into timely, actionable competitive insights.
- Develop competitive and market assessments, including landscape analyses, TPP benchmarking, SWOTs, opportunity assessments, and forecasts, to inform pipeline, portfolio, and business development strategy
- Partner with business development on licensing diligence through competitive, market, epidemiological, and forecasting analyses.
- Communicate insights through clear, concise, executive-ready presentations and deliverables
- Oversee the management of external vendors and consultants.
Qualifications:
- Bachelor's degree in a life sciences, business, or related discipline required; advanced degree (PhD, PharmD, MD, MS, or MBA) preferred.
- 6+ years of relevant experience in pharmaceutical/biotech competitive intelligence, strategy, consulting, equity research, or a closely related field.
- Proficient in the use of CI tools to support data-driven decision making.
- Experience managing CI vendors or external partners with an emphasis on quality, timeliness, and alignment to strategic goals.
- Able to synthesize primary and secondary CI and translate findings into clear, actionable implications.
- Strong collaboration, communication, and presentation skills, with the ability to influence across functions and organizational levels.
- Excellent written and verbal communication skills and advanced proficiency in Excel and PowerPoint.
- Ability to navigate a fast-paced, high-growth environment.
- Willingness to travel as needed for meetings and industry events; typically 4-6 conferences a year in the U.S. and Europe.
- Experience in AI tools an advantage
#LI-Hybrid
The position is eligible for a competitive compensation and benefits package.
Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $174,200 to $205,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.
Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans.
Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued. All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.
Similar jobs
Est. 255,392 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 203,025 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 206,238 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 121,168 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 255,828 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 254,363 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 192,959 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 151,364 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 245,000 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 246,850 USD
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business stra…
Est. 140,000 USD
About GenScript Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaki…
Est. 286,934 USD
Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person…
Est. 235,125 USD
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases.…
Est. 232,500 USD
Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immu…
Est. 170,000 USD
WHO WE ARE Zeta Global (NYSE: ZETA) is the AI-Powered Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers to acquire, grow, and retain cu…
Est. 278,000 USD
About Genetix Biotherapeutics At Genetix Biotherapeutics every role has meaning, every team member is respected, and every day is a chance to make a difference. When you join Genetix, you're not just landing a new role,…
Est. 215,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 240,000 USD
Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA…
Est. 197,500 USD
Axogen is committed to building and maintaining a strong and gratifying company culture that fosters professional growth. Our hands-on and personal approach makes transitioning to a new job a seamless and enjoyable proce…
Est. 210,000 USD
At Adaptive, we’re Powering the Age of Immune Medicine. Our goal is to harness the power of the adaptive immune system to transform the way diseases are diagnosed and treated. As an Adapter, you’ll have the opportunity t…
Est. 170,000 USD
WHO WE ARE Zeta Global (NYSE: ZETA) is the Data-Powered Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers to acquire, grow, and retain…
Est. 120,000 USD
Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; Direct-to- Patient Site and Patient Recruitment, we accelerate enrollment by expanding the r…
Est. 325,000 USD
WHO WE ARE Zeta Global (NYSE: ZETA) is the AI-Powered Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers to acquire, grow, and retain cu…
Est. 200,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 225,000 USD
WHO WE ARE Zeta Global (NYSE: ZETA) is the AI-Powered Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers to acquire, grow, and retain cu…
Est. 160,000 USD
Position: Associate Director, Product Management (MDx & Enzymes) Department: Marketing Position Type: Full time Location: Boulder, CO (preferred) Experience: MS and +12 years of relevant industry experience, includin…
Est. 259,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 189,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 190,000 USD
WHO WE ARE Zeta Global (NYSE: ZETA) is the AI-Powered Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers to acquire, grow, and retain cu…
Est. 161,500 USD
COMPANY DESCRIPTION: A career here is life-enhancing. At Syner-G, we enable our people to build careers that impact positively on their quality of life. Through our expertise, insight, consulting and management skills, w…